福安藥業(ye)(集團)股(gu)份有限公司成立于(yu)2004年2月(yue)25日(ri),公司位于(yu)重慶市長(chang)壽(shou)(shou)經濟技術(shu)開發(fa)區(qu),占地面積約(yue)100畝(mu),建筑面積3萬余平方米,注(zhu)冊資本11.89億(yi)元。是長(chang)壽(shou)(shou)經濟技術(shu)開發(fa)區(qu)在深(shen)圳創業(ye)板成功上(shang)市的企業(ye)(2011年3月(yue)22日(ri) 股(gu)票代碼(ma):300194)。
公(gong)(gong)(gong)司(si)(si)(si)旗下擁(yong)有(you)9家(jia)全(quan)資(zi)(zi)(zi)及控(kong)(kong)股(gu)子公(gong)(gong)(gong)司(si)(si)(si),分別(bie)為(wei):2008年(nian)3月(yue)成(cheng)立的(de)從(cong)事(shi)藥(yao)(yao)品研發的(de)全(quan)資(zi)(zi)(zi)子公(gong)(gong)(gong)司(si)(si)(si)福(fu)(fu)安藥(yao)(yao)業(ye)集(ji)團(tuan)(tuan)重(zhong)(zhong)慶(qing)(qing)(qing)禮邦藥(yao)(yao)物開發有(you)限公(gong)(gong)(gong)司(si)(si)(si)、2009年(nian)7月(yue)全(quan)資(zi)(zi)(zi)收購的(de)以(yi)(yi)制(zhi)劑生產(chan)為(wei)主營業(ye)務的(de)福(fu)(fu)安藥(yao)(yao)業(ye)集(ji)團(tuan)(tuan)慶(qing)(qing)(qing)余堂(tang)制(zhi)藥(yao)(yao)有(you)限公(gong)(gong)(gong)司(si)(si)(si)和(he)主要(yao)從(cong)事(shi)藥(yao)(yao)品銷售業(ye)務的(de)重(zhong)(zhong)慶(qing)(qing)(qing)生物制(zhi)品有(you)限公(gong)(gong)(gong)司(si)(si)(si)、2011年(nian)8月(yue)全(quan)資(zi)(zi)(zi)控(kong)(kong)股(gu)以(yi)(yi)制(zhi)劑生產(chan)為(wei)主營業(ye)務的(de)福(fu)(fu)安藥(yao)(yao)業(ye)集(ji)團(tuan)(tuan)湖北(bei)人(ren)民制(zhi)藥(yao)(yao)有(you)限公(gong)(gong)(gong)司(si)(si)(si)、2013年(nian)8月(yue)20日控(kong)(kong)股(gu)子公(gong)(gong)(gong)司(si)(si)(si)福(fu)(fu)安藥(yao)(yao)業(ye)集(ji)團(tuan)(tuan)重(zhong)(zhong)慶(qing)(qing)(qing)凱斯特醫(yi)藥(yao)(yao)有(you)限公(gong)(gong)(gong)司(si)(si)(si)、2014年(nian)3月(yue)全(quan)資(zi)(zi)(zi)控(kong)(kong)股(gu)的(de)從(cong)事(shi)醫(yi)藥(yao)(yao)中間體生產(chan)的(de)廣安凱特制(zhi)藥(yao)(yao)有(you)限公(gong)(gong)(gong)司(si)(si)(si)、2015年(nian)5月(yue)全(quan)資(zi)(zi)(zi)控(kong)(kong)股(gu)的(de)福(fu)(fu)安藥(yao)(yao)業(ye)集(ji)團(tuan)(tuan)寧波天(tian)衡制(zhi)藥(yao)(yao)有(you)限公(gong)(gong)(gong)司(si)(si)(si)、2016年(nian)6月(yue)全(quan)資(zi)(zi)(zi)控(kong)(kong)股(gu)的(de)煙臺只楚藥(yao)(yao)業(ye)有(you)限公(gong)(gong)(gong)司(si)(si)(si)、2016年(nian)9月(yue)從(cong)集(ji)團(tuan)(tuan)公(gong)(gong)(gong)司(si)(si)(si)剝(bo)離(li)成(cheng)立的(de)福(fu)(fu)安藥(yao)(yao)業(ye)集(ji)團(tuan)(tuan)重(zhong)(zhong)慶(qing)(qing)(qing)博圣制(zhi)藥(yao)(yao)有(you)限公(gong)(gong)(gong)司(si)(si)(si)。
公(gong)司(si)主要從事原料藥及制劑的(de)生產、銷售(shou)。目前公(gong)司(si)主要涉(she)及的(de)領(ling)域(yu)有抗感染、抗腫(zhong)瘤、精(jing)神神經(jing)系(xi)統、心腦血(xue)管、消化系(xi)統、內分泌及代(dai)謝、骨骼與肌肉系(xi)統等(deng)。
集團(tuan)公(gong)司(si)現有職工1900余人,其中博士(shi)5名,碩士(shi)48名,本科學歷404人,人才梯次和(he)結(jie)構合理。公(gong)司(si)將積(ji)極推進產(chan)(chan)品(pin)結(jie)構的優化、加快產(chan)(chan)品(pin)研(yan)發(fa)和(he)科研(yan)成(cheng)果的產(chan)(chan)業化,努力完成(cheng)由抗生素(su)產(chan)(chan)品(pin)占據(ju)主導地位向抗生素(su)與專科用藥協同發(fa)展的戰略調整,為公(gong)司(si)的未(wei)來發(fa)展奠(dian)定(ding)堅(jian)實基礎。